Pretransplant rejection risk assessment through enzyme-linked immunosorbent assay analysis of anti-HLA class I antibodies

American Journal of Kidney Diseases

Volumn 28, Issue 1, 1996, Pages 92-98

  Regan, Jeffrey ^b   Monteiro, Francisco ^b   Speiser, Daniel ^b   Kalil, Jorge ^b   Pouletty, Philippe ^b   Buelow, Roland ^a  

^a GENZYME CORPORATION   (United States)

^b NONE

Author keywords

antibody; enzyme linked immunosorbent assay; HLA; transplantation

Indexed keywords

HLA ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M;

ACUTE KIDNEY FAILURE; ALLOGRAFT; ANTIBODY SPECIFICITY; ARTICLE; CADAVER; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT REJECTION; HIGH RISK POPULATION; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION;

EID: 0029903312     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(96)90136-5     Document Type: Article

References (22)

1. Hopkins KA: Basic microlymphocytotoxicity test, in Zachary AA, Terisi GA (eds): ASHI Laboratory Manual (ed 2). Lenexa, KS, American Society of Histocompatibility and Immunogenetics, 1990, pp 195-201
2. Zmijewski C: Detection and Identification of HLA antibodies, in Zachary AA, Terisi GA (eds): ASHI Laboratory Manual (ed 2). Lenexa, KS, American Society of Histocompatibility and Immunogenetics, 1990, pp 249-262
3. Noreen HJ: Crossmatch test, in Zachary AA, Terisi GA (eds): ASHI Laboratory Manual (ed 2). Lenexa, KS, American Society of Histocompatibility and Immunogenetics, 1990, pp 307-320
4. Buelow R, Mercier I, Glanville L, Regan J, Ellingson L, Janda G, Claas F, Colombe B, Gelder F, Grosse-Wilde H, Orosz C, Westhoff U, Voegeler U, Monteiro F, Pouletty P: Detection of panel reactive anti-HLA class I antibodies by ELISA or lymphocytotoxicity: Results of a blinded, controlled multicenter study. Hum Immunol 44:1-11, 1995
5. Hopkins KA, Maguire MG, Fink NE, Bias WB: Reproducibility of HLA-A, B, and DR typing using peripheral blood samples: Results of retyping in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Group, Baltimore, MD. Hum Immunol 33:122-128, 1992
6. Marrari M, Duquesnoy R: Progress report on the ASHI/ CAP Proficiency Survey Program in Histocompatibility Testing. I. HLA-A, B, C typing, antibody screening, and lymphocytotoxicity crossmatching. Hum Immunol 39:87-95, 1994
7. Albert E: Report on the tissue typers meeting at Eurotransplant on Friday, September 27, 1991. Eurotransplant Newsletter 89:11-13, 1989
8. Doxiadis IN, Schreuder GMT, Claas FHJ: ET quality control testing of tissue typing, donor retyping, crossmatching and serum screening. Eurotransplant Newsletter 98:11-13, 1988
9. Kerman RH, Van Buren CT, Lewis RM, Kahan BD: Impact of blood transfusions and HLA on cyclosporine-treated renal transplant recipients. Transplant Proc 3:534-539, 1988 (suppl 3)
10. Koka P, Cecka JM: Sensitization and crossmatching in renal transplants, in Terasaki P (ed): Clinical Transplants 1989. Los Angeles, CA, UCLA Tissue Typing Laboratory Publications, 1990, pp 379-383
11. Terasaki P, Cicciarelli J: Sensitization and its role in transplantation, in Cerilli J (ed): Organ Transplantation and Replacement. Philadelphia, PA, Lippincott, 1988, pp 197-203
12. Doxiadis I, Westhoff U, Grosse-Wilde H: Quantification of soluble HLA class I gene products by an enzyme linked immunosorbent assay. Blut 59:449-454, 1989
13. Shimizu B, Sra K, Ferrone S, Pouletty P: sHLA-STAT class I, an ELISA for quantification of HLA antigens in serum. Hum Immunol 32:289, 1992 (suppl 1)
14. Pouletty P, Ferrone S, Amesland F, Cohen N, Westhoff U, Charron D, Shimizy R, Grosse-Wilde H: Summary Report from the First International Workshop on Soluble HLA Antigens. Paris, August 1992. Tissue Antigens 42:45-54, 1993
15. Pouletty P, Chang C, Atwood E, Kalil J, Ferrone S, Shimizu R, Howson W, Mazahari R, Del Villano B, Grumet C: Typing of serum soluble HLA-B27 by ELISA. Tissue Antigens 42:14-19, 1993
16. Tierey JM, Morel C, Freidel AC, Zwahlen F, Gebuhrer L, Betuel H, Jeannet M, Mach B: Selection of unrelated donors for bone marrow transplantation is improved by HLA class II genotyping with oligonucleotide hybridization. Proc Natl Acad Sci U S A 88:7121-7125, 1991
17. Pouletty C, Mercier I, Glanville L, Tomavo N, Igoudin L, Pouletty P, Buelow R: Typing of a panel of soluble HLA class I antigens by ELISA. Hum Immunol 40:218-227, 1994
18. Grumet FC, Buelow R, Gross-Wilde H, Pouletty P, Garavoy M: Report of the Second International Soluble HLA Workshop. Hum Immunol 40:153-165, 1994
19. Kerman RH, Susskind B, Buelow R, Regan J, Pouletty P, William J, Gerolami K, Kerman DH, Katz SM, Van Buren CT, Kahan BD: ELISA detected IgG and IgA anti-HLA antibodies in pre-transplant sera correlate with renal allograft rejection. Transplantation (in press)
20. Koka P, Chia D, Terasaki PI, Chan H, Chia J, Ozawa M, Lim E: The role of IgA anti-HLA class I antibodies in kidney transplant survival. Transplantation 56:207-211, 1993
21. Loh E, Bergin JD, Couper GS, Mudge GH: Role of panel-reactive antibody cross-reactivity in predicting survival after orthotopic heart transplantation. J Heart Lung Transplant 13:194-201, 1994
22. Gjertson DW: Multifactorial analysis of renal transplants reported to the United Network for Organ Sharing Registry, in Terasaki PI, Cecka JM (eds): Clinical Transplants. Los Angeles, CA, University of California, 1992, pp 299-317